Articles with public access mandates - Paul M Ridker, MD, MPHLearn more
OverallNIHMRCBHFWellcomeNIHRCancer Research UKEuropean CommissionAHASwedish Research CouncilNHMRCESRCCIHRDFGSNSFNWOBBSRCZonMwLeducq Foundation, USAVACSODoris Duke Charitable FoundationINSERMGovernment of ItalyAcademy of FinlandBMBFFWFDHFVersus Arthritis, UKFRQSARCDFFHelmholtzDiabetes UKGovernment of SpainMacArthurHealth Data Research, UKRCNJDRFUSDAHSFNSERCUK Research & InnovationKnut and Alice Wallenberg FoundationA*StarEPSRCNSFGenome CanadaDCTIFondazione CariploANRNMRCSusan G. KomenDoDHHMIFWONSFCDNRFDSFAlzheimers's UKDMTAction on Hearing Loss, UKKNAWPCORIKWFAIRC Foundation for Cancer Research in ItalyNational Research Foundation, SingaporeDOEGatesTekesSFIFormasFORTEBreast Cancer Now, UKBusiness FinlandWorld Cancer Researh Fund, UKJSTCCSIDRCCSIRDBTDSTTelethonFCTMarianne and Marcus Wallenberg FoundationBlood Cancer UKProstate Cancer UKState of CalifoniaNCNDamon Runyon Cancer Research FoundationRoyal Society UKMedical Research Future Fund, AustraliaMinistry of Health, Singapore
Not available anywhere: 44
Gene Variation of Endoplasmic Reticulum Aminopeptidase 1 and Risk of Incident Type 2 Diabetes Mellitus amongst 22,718 Initially Healthy Women
JR Romero, PM Ridker, DI Chasman, RYL Zee
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) 4 (1), 70-74, 2017
Mandates: US National Institutes of Health
Demystifying HDL Cholesterol—A “Human Knockout” to the Rescue?
AV Khera, PM Ridker
Clinical Chemistry 63 (1), 33-36, 2017
Mandates: US National Institutes of Health
Complete blood count risk score and its components, including RDW, are associated with mortality in the JUPITER trial
BD Horne, JL Anderson, JB Muhlestein, PM Ridker, NP Paynter
European journal of preventive cardiology 22 (4), 519-526, 2015
Mandates: US National Institutes of Health
JCL Roundtable: is inflammation a future target in preventing arteriosclerotic cardiovascular disease
WV Brown, AT Remaley, PM Ridker
Journal of Clinical Lipidology 9 (2), 119-128, 2015
Mandates: US National Institutes of Health
Statin Therapy and Risk of Fracture.
JM Peña, S Aspberg, J MacFadyen, RJ Glynn, DH Solomon, PM Ridker
JAMA Internal Medicine 175 (2), 2015
Mandates: US National Institutes of Health
Safety profile of subjects treated to very low low-density lipoprotein cholesterol levels (< 30 mg/dl) with rosuvastatin 20 mg daily (from JUPITER)
BM Everett, S Mora, RJ Glynn, J MacFadyen, PM Ridker
The American journal of cardiology 114 (11), 1682-1689, 2014
Mandates: US National Institutes of Health
Cholesteryl ester transfer protein polymorphisms, statin use, and their impact on cholesterol levels and cardiovascular events
M Leusink, NC Onland‐Moret, FW Asselbergs, B Ding, S Kotti, ...
Clinical Pharmacology & Therapeutics 95 (3), 314-320, 2014
Mandates: US National Institutes of Health, Wellcome Trust, Netherlands Organisation …
Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy
JS Danik, DI Chasman, JG MacFadyen, F Nyberg, BJ Barratt, PM Ridker
American heart journal 165 (6), 1008-1014, 2013
Mandates: US National Institutes of Health, Doris Duke Charitable Foundation
Coronary Artery Calcium Scanning and Conflicts of Interest—Reply
PM Ridker
Archives of Internal Medicine 172 (8), 670-670, 2012
Mandates: US National Institutes of Health
Effect of Rosuvastatin on Hemoglobin Levels in Patients With Anemia and Low‐Grade Inflammation: A Post Hoc Analysis of the JUPITER Trial
MA Brookhart, DH Solomon, RJ Glynn, PM Ridker
The Journal of Clinical Pharmacology 51 (10), 1483-1487, 2011
Mandates: US National Institutes of Health
The editor's roundtable: JUPITER follow-up
VE Friedewald, CM Ballantyne, MH Davidson, AM Gotto, PM Ridker, ...
American Journal of Cardiology 107 (10), 1549-1557, 2011
Mandates: US National Institutes of Health
Venous thromboembolism in patients with symptomatic atherosclerosis
G Piazza, SZ Goldhaber, DM Lessard, RJ Goldberg, C Emery, ...
Thrombosis and haemostasis 106 (12), 1095-1102, 2011
Mandates: US National Institutes of Health
The JUPITER Trial: responding to the critics
PM Ridker, RJ Glynn
American Journal of Cardiology 106 (9), 1351-1356, 2010
Mandates: US National Institutes of Health
Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an …
PM Ridker, J MacFadyen, P Libby, RJ Glynn
The American journal of cardiology 106 (2), 204-209, 2010
Mandates: US National Institutes of Health
Moving toward new statin guidelines in a post-JUPITER world: principles to consider
PM Ridker
Current atherosclerosis reports 11 (4), 249-256, 2009
Mandates: US National Institutes of Health
Should patients with rheumatoid arthritis receive statin therapy?
PM Ridker, DH Solomon
Arthritis & Rheumatism 60 (5), 1205-1209, 2009
Mandates: US National Institutes of Health
Measures to assess the prognostic ability of the stratified Cox proportional hazards model
Fibrinogen Studies Collaboration
Statistics in Medicine 28 (3), 389-411, 2009
Mandates: British Heart Foundation
AJC editor's consensus: psoriasis and coronary artery disease
VE Friedewald, JC Cather, JM Gelfand, KB Gordon, GH Gibbons, ...
American Journal of Cardiology 102 (12), 1631-1643, 2008
Mandates: US National Institutes of Health
Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in southeastern New England
CB Eaton, R Gramling, DR Parker, MB Roberts, B Lu, PM Ridker
Atherosclerosis 200 (1), 221-227, 2008
Mandates: US National Institutes of Health
The editor’s roundtable: psoriasis, inflammation, and coronary artery disease
VE Friedewald, JC Cather, KB Gordon, A Kavanaugh, PM Ridker, ...
American Journal of Cardiology 101 (8), 1119-1126, 2008
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program